MEDLEYFRA:3YV +2.80%74 PB Ratio is 4.19 as of Jul. 02, 2026, which is 39% below its 10-year median of 6.87. GuruFocus rates FRA:3YV with a GF Score™ of 74/100 and a GF Value™ of €36.41 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 609 Healthcare Providers & Services companies, MEDLEY ranks worse than 76.85% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-02), MEDLEY's share price is €11.00. MEDLEY's Book Value per Share for the quarter that ended in Dec. 2025 was €2.62. Hence, MEDLEY's PB Ratio of today is 4.19.
The historical rank and industry rank for MEDLEY's PB Ratio or its related term are showing as below:
FRA:3YV'
s PB Ratio Range Over the Past 10 Years
Min: 3.65 Med: 6.87 Max: 35.66
Current: 4.2
During the past 7 years, MEDLEY's highest PB Ratio was 35.66. The lowest was 3.65. And the median was 6.87.
FRA:3YV's PB Ratio is ranked worse than 76.85% of 609
companies
in the Healthcare Providers & Services industry
Industry Median: 1.96
vs FRA:3YV: 4.20
During the past 12 months, MEDLEY's average Book Value Per Share Growth Rate was -22.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 0.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 9.90% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of MEDLEY was 57.90% per year. The lowest was 0.60% per year. And the median was 16.10% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
MEDLEY PB Ratio Related Terms
MEDLEY PB Ratio Historical Data
* Premium members only.
The historical data trend for MEDLEY's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, MEDLEY's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MEDLEY PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MEDLEY's PB Ratio distribution charts can be found below:
* The bar in red indicates where MEDLEY's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
MEDLEY's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
MEDLEY (FRA:3YV) has a PB Ratio of 4.19 as of Jul. 02, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MEDLEY and its competitors. This is 39% below median its historical median of 6.87. Over the past decade, MEDLEY's PB Ratio has ranged from 3.65 to 35.66. According to the industry distribution chart, MEDLEY ranks #468 out of 609 companies in the Healthcare Providers & Services industry, placing it in the top 76.8%.
Is MEDLEY's PB Ratio too high?
MEDLEY's current PB Ratio of 4.19 is 39% below median its 10-year median of 6.87. Over the past 10 years, this metric has ranged from a low of 3.65 to a high of 35.66. The Healthcare Providers & Services industry median PB Ratio is 1.96. MEDLEY's value of 4.19 is 113.8% above this industry median. Based on the distribution chart, MEDLEY ranks #468 out of 609 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, MEDLEY has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MEDLEY's PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MEDLEY ranks #468 out of 609 companies for PB Ratio. This places MEDLEY in the lower half of its industry. The industry median PB Ratio is 1.96. MEDLEY's value of 4.19 is 113.8% above this benchmark. Historically, MEDLEY's own PB Ratio has ranged from 3.65 to 35.66 over the past decade. While the company's 10-year median is 6.87 vs. the industry median of 1.96, MEDLEY has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.96, based on 609 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MEDLEY's current PB Ratio of 4.19 is 113.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MEDLEY and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MEDLEY's current PB Ratio is 4.19, which is 39% below median its own 10-year median of 6.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDLEY stock overvalued right now?
Based on GuruFocus' analysis, MEDLEY (FRA:3YV) is currently considered Significantly Undervalued. The stock's GF Value™ is €36.41, compared to a current price of €11.00 — trading 69.8% below its estimated fair value. The current PB Ratio is 4.19, which is 39% below median its 10-year median of 6.87 and 113.8% above the Healthcare Providers & Services industry median of 1.96. MEDLEY's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For MEDLEY (FRA:3YV), the current PB Ratio is 4.19 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MEDLEY (FRA:3YV) Overvalued in 2026?
Based on GuruFocus' analysis, MEDLEY stock appears to be undervalued.
The current stock price of €11.00 is trading 69.8% below its estimated GF Value™ of €36.41.
GuruFocus considers MEDLEY to be Significantly Undervalued.
Key valuation signals for FRA:3YV:
PB Ratio: 4.19 (39% below median its 10-year median of 6.87)
GF Value™: €36.41 vs. price of €11.00 (69.8% below fair value)
Industry Position: 113.8% above the Healthcare Providers & Services median (#468 of 609)
No single metric tells the full story. See the FRA:3YV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MEDLEY Inc is engaged in providing medical information service for patients, and nursing care, a nursing care information service for citizens resolving issues in the field of medical healthcare. It provides its services through two platforms, Recruitment Platform Business which provides human resource recruitment systems in the medical and healthcare field and related businesses; and Medical Platform Business that is a telemedicine system for both patients and medical institutions.
74GF Score
Get the complete analysis for FRA:3YV
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3YV has been successfully added to your 
